Correlation Between Broadcom and Foghorn Therapeutics

Can any of the company-specific risk be diversified away by investing in both Broadcom and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Broadcom and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Broadcom and Foghorn Therapeutics, you can compare the effects of market volatilities on Broadcom and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Broadcom with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Broadcom and Foghorn Therapeutics.

Diversification Opportunities for Broadcom and Foghorn Therapeutics

0.71

Correlation Coefficient

Broadcom  Foghorn Therapeutics

Poor diversification

The 3 months correlation between Broadcom and Foghorn is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Broadcom and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Broadcom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Broadcom are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Broadcom i.e., Broadcom and Foghorn Therapeutics go up and down completely randomly.

Pair Corralation between Broadcom and Foghorn Therapeutics

Given the investment horizon of 90 days Broadcom is expected to generate 0.44 times more return on investment than Foghorn Therapeutics. However, Broadcom is 2.28 times less risky than Foghorn Therapeutics. It trades about 0.25 of its potential returns per unit of risk. Foghorn Therapeutics is currently generating about 0.07 per unit of risk. If you would invest  23,157  in Broadcom on May 14, 2025 and sell it today you would earn a total of  7,233  from holding Broadcom or generate 31.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Broadcom  vs.  Foghorn Therapeutics

Broadcom

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Broadcom are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Broadcom displayed solid returns over the last few months and may actually be approaching a breakup point.

Foghorn Therapeutics

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Foghorn Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Foghorn Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Broadcom and Foghorn Therapeutics

The main advantage of trading using opposite Broadcom and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Broadcom position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.

The idea behind Broadcom and Foghorn Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.